Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2010

Mar 23, 2010

30339_dirs_2010-03-23_a26596e6-ddbc-4688-9ebd-8d3220774d69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2010-03-22

Reporting Person: LUZZI RICHARD D (VP, Human Resources)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-03-22 Stock Option (Right to Buy) $42.68 A 16393 Acquired 2020-03-22 Common Stock (16393) Direct